These results suggested that PPARγ-mediated increase of PTEN expressions may inhibit the PI3K/Akt activity, leading to reduction of GLUT4 expressions and thus the development of insulin resistance in IUGR offsprings. The gene discussed is SLC2A4; the disease is fetal growth restriction.